Polygenic risk score improves psychosis risk prediction

November 12, 2019

CHAPEL HILL, N.C. - November 12, 2019 - A new study led by researchers at the University of North Carolina at Chapel Hill has found that that using a polygenic risk score (PRS) based on data from genome-wide association studies (GWAS) improves psychosis risk prediction in persons meeting clinical high-risk criteria.

"Previous studies reported the PRS discriminates persons with established schizophrenia from unaffected persons. Our study is the first to indicate the PRS predicts future psychosis suggesting a PRS may facilitate the development and eventual targeting of preemptive interventions," said Diana O. Perkins, MD, MPH, a professor of psychiatry in the UNC School of Medicine and lead author of the study, published Nov. 12 in the American Journal of Psychiatry.

Schizophrenia is typically a chronic and disabling disorder affecting about 1 percent of adolescents and young adults. Research criteria for a clinical high-risk syndrome identify persons with a 15-25 percent 2-year risk of psychosis. While the 2-year risk of psychosis in persons meeting research criteria for a high-risk syndrome is about 200-fold higher than the general population risk, the prediction accuracy is still not optimal for the development and implementation of preventative interventions.

Large-scale, genome-wide association studies (GWAS) developed a polygenetic risk score (PRS) that discriminates persons with schizophrenia from persons without schizophrenia. "In this study, we discovered that the PRS improves psychosis risk prediction in persons meeting clinical high-risk criteria," Perkins said. "Moreover, the PRS improved individualized risk assessments as part of our previously published Psychosis Risk Calculator."

However, because the PRS was developed in persons of mainly European ancestry, the PRS did not perform as well in non-Europeans and it did in Europeans, Perkins said. Improvements in PRS construction methods and efforts to include non-Europeans in genetic risk studies are needed. With further improvements and given the relatively low cost and wide-availability of genotyping, potential applications of genetic risk scores to psychosis risk screening warrant further exploration, Perkins said.
Co-authors of the study include Clark D. Jeffries, PhD, of UNC's Renaissance Computing Institute (RENCI), Loes Olde Loohuis, PhD (UCLA), Jenna Barbee (UNC Department of Psychiatry) and North American Prodrome Longitudinal Study (NAPLS) consortium investigators.

University of North Carolina Health Care

Related Psychosis Articles from Brightsurf:

Unravelling the origins of autoimmune psychosis
Anti-NMDAR encephalitis is an autoimmune brain illness that is often mistaken by a psychiatric disorder since it causes psychoses and other behaviour alterations.

Targeted treatment for depression could benefit patients with psychosis
Patients with early onset psychosis may benefit from treatment for depression, including with anti-depressants alongside other medication, new research shows.

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial
New data presented at the Alzheimer's Association International Conference indicates that pimavanserin leads to a robust reduction in the severity of psychosis symptoms during the 12 week open-label phase of the study, regardless of the underlying dementia subtype or the severity of participants' dementia.

Young people with early psychosis may not require antipsychotic medications to recover
Researchers at Orygen have found that some young people with early stage first episode psychosis (FEP) can experience reduced symptoms and improve functioning without antipsychotic medication when they are provided with psychological interventions and comprehensive case management.

NMDA receptors may link psychosis and sleep deficits
Sofya Kulikova, a researcher at HSE University in Perm, is part of an international research team that has discovered potential mechanisms that explain the sleep spindle deficit in electroencephalograms (EEG) of people with schizophrenia.

Almost half of all postpartum psychosis are isolated cases
A new research result from iPSYCH shows that 40% of the women who suffer a psychosis after giving birth -- known as postpartum psychosis - do not subsequently become ill again.

Thirty risk factors found during and after pregnancy for children developing psychosis
More than 30 significant risk factors have been identified for the development of psychotic disorders in offspring in research led by the NIHR Maudsley BRC.

A new window into psychosis
A recent study in mice led a team of researchers in Japan to believe that psychosis may be caused by problems with specialized nerve cells deep within the brain, as well as a certain kind of learning behavior.

New insight into how cannabidiol takes effect in the brains of people with psychosis
Researchers from King's College London have shown that cannabidiol (CBD) alters the brain activity in people with psychosis during memory tasks, making it more similar to the activation seen in people without psychosis during the same tasks.

Study finds 'cluster of disadvantage' behind BAME psychosis rates
Excess psychosis diagnoses amongst black and South Asian men in deprived urban areas could reflect a cluster of disadvantage in specific places, rather than individual experiences of deprivation alone, a study led by Queen Mary University of London researchers concludes.

Read More: Psychosis News and Psychosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.